Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon
Granules India

十一月 2025

十一月 2025的Granules India市场份额分析

Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets.
成立年份1984
员工1001 - 5000
年营收$500M - $1B
granulespharma.com
sennchem.com
granulesindia.com
Granules India
显示 Granules India 主网站(包括公司地区网站)的流量和参与度信息
  • granulesindia.com
    granulesindia.com
  • granulespharma.com
    granulespharma.com
  • sennchem.com
    sennchem.com
查看更多网站流量和参与度信息

Granules India收入截至 十一月 2025为 500M - 1B

Granules India主要域名产生的收入

3 年中Granules India主要域名的收入

Granules India主要域名的收入

granulesindia.comgranulesindia.com500M - 1B
sennchem.comsennchem.com15M - 25M
使用销售情报查看更多信息

Granules India热门域名的总访问量

了解Granules India市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细
granulesindia.comgranulesindia.com12.4K
granulespharma.comgranulespharma.com4.3K
sennchem.comsennchem.com431
使用销售情报查看更多信息

Granules India热门域名的平均访问时长

分析Granules India参与度指标。

过去 3 个月的平均访问时长

子公司明细
granulesindia.comgranulesindia.com00:00:31
granulespharma.comgranulespharma.com00:03:07
sennchem.comsennchem.com--
使用销售情报查看更多信息

Granules India热门域名的平均页面浏览量

了解Granules India如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细
granulesindia.comgranulesindia.com2.10
granulespharma.comgranulespharma.com2.07
sennchem.comsennchem.com1.03
使用销售情报查看更多信息

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Granules India 采用的主要技术

这些是排名前 Granules India 的顶级域名所使用的网站技术(按行业分列)

电子商务 (4)

视听媒体 (2)

转化和分析 (2)

Google Analytics

Google Analytics

电子邮件服务 (2)

Sendgrid

Sendgrid

更多技术

8

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Granules India 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻Granules India Limited invests into assets: 100 acres of land within Green Pharma City in the amount of $133M in India.Granules India, which has proposed to establish advanced facilities for the manufacturing of peptides, along with a Contract Development and Manufacturing Organization (CDMO) for oncology products in Telangana with an investment of Rs.1,200 crore, has also requested 100 acres of land within Green Pharma City.
新闻Granules India Limited partnered with Niperahm on Sep 5th '25.Granules India Limited, in partnership with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, today inaugurated the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).
新闻Granules India Limited launched Corporate Social Responsibility initiative to support 1,030 tuberculosis patients in Bhadradri Kothagudem District, Telangana on May 14th '25.Bengaluru: Granules India Limited, a leading pharmaceutical company, today launched its Corporate Social Responsibility (CSR) initiative to support 1,030 tuberculosis (TB) patients in Bhadradri Kothagudem District, Telangana.

查看 Granules India 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。